InsidersTradesSigma
Track the SenesTech, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Energy sector, SenesTech, Inc. has logged 23 reports. Market capitalisation: €5.7m. The latest transaction was disclosed on 10 September 2026 (Acquisition). Among the most active insiders: GLENBROOK CAPITAL MANAGEMENT. All data is accessible without an account.
23
Insider Decl.
n/a
Thresholds
€497,563
19 ops.
Buy Volume
€147
2 ops.
Sell Volume
53Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,368 of 29,064 companies
21.1
score / 100
Value1
Quality41
FCF yld-103%
Earn yld-111%
EV/EBITDA·
ROE-107%
Gross mgn62%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 September 2026
Declarations23 total
1,000 shares@ US$0.89Common StockSEC:0001628280-26-061448:0
Canonical exit: 8 Dec 2026 (T+90)
1,000 shares@ US$0.85Common StockSEC:0001628280-26-061448:1
Canonical exit: 8 Dec 2026 (T+90)
1,000 shares@ US$1.210.019% mcap45.6% of flowCommon StockSEC:0001628280-26-057423:0
Canonical exit: 12 Nov 2026 (T+90)
15,000 shares@ US$1.29620.28% mcap3.9% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-003373:0
Canonical exit: 4 Nov 2026 (T+90)
6,490 shares@ US$1.29770.12% mcap1.7% of flowCommon StockSEC:0000902664-26-003373:1
Canonical exit: 5 Nov 2026 (T+90)
35,000 shares@ US$1.47340.69% mcap11.1% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-003205:0
Canonical exit: 18 Oct 2026 (T+90)
1,000 shares@ US$1.42990.018% mcap100.0% of flowCommon StockSEC:0001628280-26-047673:0
Canonical exit: 5 Oct 2026 (T+90)
3,990 sharesCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-002947:0
Canonical exit: 22 Sept 2026 (T+90)
9,442 sharesCommon StockSEC:0000902664-26-002947:1
Canonical exit: 23 Sept 2026 (T+90)
6,812 sharesCommon StockSEC:0000902664-26-002947:2
Canonical exit: 24 Sept 2026 (T+90)
5,172 sharesCommon StockSEC:0000902664-26-002947:3
Canonical exit: 27 Sept 2026 (T+90)
1,000 sharesCommon StockSEC:0001628280-26-041901:0
Canonical exit: 6 Sept 2026 (T+90)
3,000 shares@ US$1.4690.054% mcap100.0% of flowCommon Stock, $0.001 par value per shareSEC:0000902664-26-002222:0
Canonical exit: 27 Jul 2026 (T+90)
146,249 shares@ US$1.951798.5% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-001650:0
Canonical exit: 11 Jun 2026 (T+90)
40,807 shares@ US$2.291122.0% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-001203:0
Canonical exit: 18 May 2026 (T+90)
8,000 shares@ US$1.73423.2% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-001004:0
Canonical exit: 12 May 2026 (T+90)
5,685 shares@ US$1.82472.4% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-000780:0
Canonical exit: 5 May 2026 (T+90)
5,399 shares@ US$1.87182.4% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-26-000679:0
Canonical exit: 30 Apr 2026 (T+90)
62 shares@ US$2.710.2% of flowCommon StockSEC:0001628280-25-053306:0
1 shares@ US$2.75100.0% of flowCommon StockSEC:0001628280-25-052557:0
18,799 shares0Common StockSEC:0001628280-23-020358:0
18,797 shares0Common StockSEC:0001209191-22-061723:0
50,000 shares@ US$1.537799.8% of flowCommon StockSEC:0001225208-21-011565:0
Canonical exit: 14 Nov 2021 (T+90)
23 of 23 declarations
关于 SenesTech, Inc.
SenesTech, Inc.（股票代码：SNES）是一家在美国纳斯达克股票市场上市的美国公司。它是一家小型、利基的环保和专业害虫管理企业，而非广泛的工业供应商。该公司于2004年7月在内华达州注册成立，总部位于亚利桑那州凤凰城，其制造基地也设在此地。对于法国、比利时和瑞士的投资者而言，SenesTech 最好被理解为一家差异化的商业阶段公司，专注于一个特定且相对服务不足的领域：鼠类种群的生育控制。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1680378/000162828025012408/snes-20241231.htm?utm_source=openai)) SenesTech 的核心业务围绕专有解决方案构建，旨在通过生育控制而非传统的致死控制来管理动物害虫种群。其旗舰产品是 ContraPest，该公司称其为唯一获得 EPA 注册的针对雄性和雌性老鼠的节育产品。其产品组合还包括 Evolve 和 Elevate Bait System，这使得该公司能够扩展到包括农业环境在内的更多应用场景。这赋予了 SenesTech 清晰的产品定位：它不是一家普通的害虫防治公司，而是人道鼠类种群管理的专家，并具有以可持续发展为导向的价值主张。（[senestech.com](https://senestech.com/pages/about?utm_source=openai)) 从竞争角度来看，该公司的吸引力在于其差异化。传统的灭鼠方法严重依赖毒药和陷阱，而 SenesTech 则将其技术定位为一种长期种群减少工具，可供害虫管理专业人员、动物园、保护区和农业客户使用。这种专业化可能会在公共认知、安全或可持续性至关重要的领域创造战略优势，但也意味着公司依赖客户教育、监管批准和专业采用来实现规模化。换句话说，SenesTech 更多地通过产品独特性而非价格或分销广度进行竞争。（[senestech.com](https://senestech.com/pages/humane-rat-control?utm_source=openai)) 从地理上看，SenesTech 的业务集中在美国。该公司还强调了某些产品（包括 Elevate Bait System）在全国范围内的可用性，此前加州的监管批准扩大了其市场范围。这表明其商业化模式以美国为中心，并有可能在五十个州实现更广泛的渗透，尽管该业务仍处于规模化早期阶段。（[senestech.com](https://senestech.com/blogs/news/elevate-bait-system%E2%84%A2-with-contrapest%C2%AE-is-now-available-in-california?utm_source=openai)) 近期公司发展突出显示了领导层的过渡期。2026年1月，首席执行官 Joel L. Fruendt 宣布退休，其离职日期定于2026年6月30日或继任者任命之日（以较早者为准）。2026年5月6日，公司任命 Michael Edell 为总裁兼首席执行官。公司还继续在2025年末和2026年第一季度提交 SEC 报告，强调在领导层变动期间持续进行公开市场披露。总的来说，SenesTech 是一家纳斯达克上市的美国微型市值公司，其创新主导的理念围绕人道鼠类生育控制、监管扩展和商业采用。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1680378/000162828026003905/snes-20260128.htm?utm_source=openai))
